Summary

Psoriatic arthritis occurs in about 30% of patients with psoriasis and is prevalent in an estimated 0.3% to 1.0% of the general population. This article reports on results from the Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis [PALACE4; NCT01307423].